Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

NovoGlia Inc
Profile last edited on: 1/17/2024      CAGE: 8KA64      UEI: JZZKDKNVJQM5

Business Identifier: Stem cell platform for treatment of neurodegenerative diseases
Year Founded
2020
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1 University Drive
Aliso Viejo, CA 92656
   (808) 989-2936
   N/A
   www.novoglia.com
Location: Single
Congr. District: 40
County: Orange

Public Profile

NovoGlia Inc is structured around development of a stem cell platform addressing treatment of neurodegenerative diseases. The company has developed a platform technology designed to use induced human pluripotent stem cells (iPSCs) to generate genetically corrected microglia for the treatment of neurodegenerative microgliopathies.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$1,197,863
Phase II Dollars
$0
Total Awarded
$1,197,863

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $399,859
Project Title: Enhancing the Engraftment of Microglia for the Treatment of Neurological Disease
2021 1 NIH $399,002
Project Title: Development of a stem cell platform for the treatment of neurodegenerativemicrogliopathies
2021 1 NIH $399,002
Project Title: Development of a stem cell platform for the treatment of neurodegenerative microgliopathies

Key People / Management

  Mathew Blurton-Jones

  Whitney England

  Sunil Gandhi

  Jonathan Hasselmann -- Prinicipal Scientist

  Robert Spitale

Company News

There are no news available.